| 2025-04-30 | -0.15 % |
|
| 2025-04-29 | +1.51 % |
|
| 2025-04-28 | -3.14 % |
|
| 2025-04-25 | +1.31 % |
|
| 2025-04-23 | -2 % |
|
| 2025-04-14 | +1.04 % |
|
| 2025-04-10 | +1.74 % |
|
| 2025-04-09 | +1.84 % |
|
| 2025-04-07 | -2.69 % |
|
| 2025-04-04 | -4.52 % |
|
| 2025-04-02 | -0.37 % |
|
| 2025-04-01 | +0.21 % |
|
| 2025-03-31 | +0.95 % |
|
| 2025-03-28 | -0.4 % |
|
| 2025-03-24 | +0.66 % |
|
| 2025-03-20 | -0.18 % |
|
| 2025-03-17 | +0.99 % |
|
| 2025-03-13 | -0.33 % |
|
| 2025-03-06 | +1.68 % |
|
| 2025-02-27 | +0.03 % |
|
| 2025-02-24 | +0.72 % |
|
| 2025-02-19 | +1.19 % |
|
| 2025-02-18 | +0.41 % |
|
| 2025-02-11 | +1.64 % |
|
| 2025-02-07 | +1.26 % |
|
| 2025-02-06 | -1.09 % |
- Colgate-Palmolive (CL) stock declined by 1.09% after JPMorgan Chase & Co. reduced its price target for the stock from $103.00 to $97.00, contributing to a trend of lowered price targets from various analysts.
- Colgate-Palmolive's stock (NYSE:CL) is down 1.09% amid recent analyst downgrades of its price targets, with JPMorgan, Barclays, Stifel Nicolaus, TD Cowen, and UBS Group all revising their price objectives lower due to various market conditions and concerns regarding the company's performance.
- Colgate-Palmolive (CL) stock decreased by 1.09% following multiple downgrades and price target reductions from several brokerages, including a cut from Stifel Nicolaus from $95.00 to $93.00, indicating a general sentiment of caution among analysts toward the stock.
- Colgate-Palmolive (CL) stock declined by -1.09% after UBS cut its price target from $104.00 to $100.00, which is part of a broader trend where several analysts have lowered their price targets on the stock, indicating reduced confidence in its performance.
|
| 2025-02-05 | +0.14 % |
|
| 2025-02-04 | -0.61 % |
|
| 2025-01-31 | -4.61 % |
|
| 2025-01-29 | -0.32 % |
|
| 2025-01-23 | +0.41 % |
|
| 2025-01-22 | -0.77 % |
|
| 2025-01-16 | +0.8 % |
|
| 2025-01-15 | +0.22 % |
- Colgate-Palmolive's stock, which was up 0.22%, benefited from increased institutional investment, as several hedge funds expanded their holdings during the last quarter, indicating positive sentiment towards the company's future prospects.
- Colgate-Palmolive (CL) stock has seen a slight increase of 0.22% as it maintains a "Moderate Buy" consensus rating among analysts, despite some recent downgrades from various firms, likely driven by a combination of adjusted price targets, ongoing institutional investment, and a recently declared quarterly dividend.
The stock's rise can be attributed to positive analyst sentiment regarding its potential for growth and profitability, despite the mixed ratings from some analysts.
- Colgate-Palmolive (CL) stock experienced a slight increase of 0.22% due to its stronger revenue growth, better profitability, and lower financial risk compared to its peer Kimberly-Clark (KMB), making it a more attractive investment choice.
|
| 2025-01-14 | +0.65 % |
|
| 2025-01-13 | +0.86 % |
|
| 2025-01-10 | -1.26 % |
|
| 2025-01-07 | -0.17 % |
|
| 2025-01-06 | -2.9 % |
|
| 2025-01-03 | -0.44 % |
|
| 2025-01-02 | -0.4 % |
|
| 2024-12-18 | -0.79 % |
|
| 2024-12-16 | -0.56 % |
|
| 2024-12-05 | +0.31 % |
|
| 2024-11-29 | -0.13 % |
|
| 2024-11-27 | +0.19 % |
|
| 2024-11-22 | +0.71 % |
|
| 2024-11-18 | +1.13 % |
|
| 2024-11-12 | -0.5 % |
|
| 2024-11-06 | -4.29 % |
|
